Article

AJMC in the Press, November 11, 2016

Author(s):

A review of our peer-reviewed research in the healthcare and mainstream press.

RevenueCycle Intelligence included a June study from The American Journal of Managed Care (AJMC) in its recent story, “Key Ways to Succeed Under MACRA’s Quality Payment Program.” The AJMC study, “Risk Contracting and Operational Capabilities in Large Medical Groups During National Healthcare Reform,” found that only one-third of providers have linked at least 50% of revenue to a risk-based alternate payment model. This slow pace of reform has limited the pace of progress in value-based care, even though CMS has set aggressive goals for Medicare.

A new study in AJMC showing the value of nonclinical benefits for patients with chronic diseases, such as increased productivity and “peace of mind,” received attention this week in news outlets, including Yahoo Finance. Diseases like multiple sclerosis (MS) cause patients fatigue and memory problems, which can limit productivity. Payers that cover newer therapies for MS create value for society, but these benefits often go unrecognized, the study asserted.

Related Videos
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD
Galen Shearn-Nance, BS
Dr Johnie Rose
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Tiffany Meng, PharmD, oncology pharmacist, UCSF Health
Dr Andrew S. Oseran
o Richard Hughes IV, JD, MPH, Epstein Becker Green
Dr Andrew S. Oseran
Dr Andrew S. Oseran
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo